{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:43:05Z","timestamp":1793932985854,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.biopha.2018.06.076","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T13:08:33Z","timestamp":1529413713000},"page":"992-996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome"],"prefix":"10.1016","volume":"105","author":[{"given":"Alberto","family":"Mazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Schiavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Di Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Manunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioia","family":"Torin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyelle M.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2018.06.076_bib0005","first-page":"21","article-title":"A comprehensive review on metabolic syndrome","author":"Kaur","year":"2014","journal-title":"Cardiol. Res. Pract."},{"key":"10.1016\/j.biopha.2018.06.076_bib0010","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0889-8529(03)00070-7","article-title":"Obesity and hypertension","volume":"32","author":"El-Atat","year":"2003","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.biopha.2018.06.076_bib0015","first-page":"2304","volume":"9","author":"European Food Safety Authority (EFSA)","year":"2011","journal-title":"EFSA J."},{"key":"10.1016\/j.biopha.2018.06.076_bib0020","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/HJH.0b013e3283395208","article-title":"Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia","volume":"28","author":"Izzo","year":"2010","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2018.06.076_bib0025","first-page":"133","article-title":"Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet","volume":"4","author":"Trimarco","year":"2011","journal-title":"Med. J. Nutr. Metab."},{"key":"10.1016\/j.biopha.2018.06.076_bib0030","first-page":"121","article-title":"Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome","volume":"7","author":"Cicero","year":"2009","journal-title":"Curr. Top. Nutraceutical Res."},{"key":"10.1016\/j.biopha.2018.06.076_bib0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13749-012-0018-y","article-title":"Long-term efficacy and tolerability of a multicomponent lipid-lowering nutraceutical in overweight and normo- weight patients","volume":"11","author":"Cicero","year":"2012","journal-title":"Nutrafood"},{"key":"10.1016\/j.biopha.2018.06.076_bib0040","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","article-title":"Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients","volume":"28","author":"Marazzi","year":"2011","journal-title":"Adv. Ther."},{"key":"10.1016\/j.biopha.2018.06.076_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.pharmthera.2009.07.003","article-title":"Role of coenzyme Q10 (CoQ10) in cardiac disease, hypertension and Meniere-like syndrome","volume":"124","author":"Kumar","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2018.06.076_bib0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.atherosclerosis.2011.04.034","article-title":"Relationship between plasma coenzyme Q10, asymmetric dimethylarginine and arterial stiffness in patients with phenotypic or genotypic familial hypercholesterolemia on long term statin therapy","volume":"218","author":"Young","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.biopha.2018.06.076_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nut.2012.03.016","article-title":"Beneficial effects of aged garlic extract and coenzyme Q10 on vascular elasticity and endothelial function: the FAITH randomized clinical trial","volume":"29","author":"Larijani","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/j.biopha.2018.06.076_bib0060","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/sj.ejcn.1601464","article-title":"Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes","volume":"56","author":"Hodgson","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.biopha.2018.06.076_bib0065","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.jhh.1000778","article-title":"Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease","volume":"13","author":"Singh","year":"1999","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.biopha.2018.06.076_bib0070","series-title":"National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Executive Summary","year":"2001"},{"key":"10.1016\/j.biopha.2018.06.076_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.curtheres.2014.07.003","article-title":"Efficacy and tolerability of a nutraceutical combination (red yeast rice, policosanols and berberine) in low-moderate risk hypercholesterolemic patients: a double-blind, placebo controlled study","volume":"77","author":"Gonnelli","year":"2015","journal-title":"Curr. Ther. Res."},{"key":"10.1016\/j.biopha.2018.06.076_bib0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2431-14-175","article-title":"Mediterranean-style diet reduces metabolic syndrome components in obese children and adolescents with obesity","volume":"14","author":"Vel\u00e1zquez-L\u00f3pez","year":"2014","journal-title":"BMC Pediatr."},{"issue":"S1","key":"10.1016\/j.biopha.2018.06.076_bib0085","first-page":"S5","article-title":"The beneficial effect of modest weight loss on cardiovascular risk factors","volume":"21","author":"Van Gaal","year":"1997","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2018.06.076_bib0090","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11906-007-0068-5","article-title":"Weight reduction for treatment of obesity-associated hypertension: nuances and challenges","volume":"9","author":"Mark","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.biopha.2018.06.076_bib0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.003","article-title":"A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence","volume":"24","author":"Barrios","year":"2017","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.biopha.2018.06.076_bib0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J. Cardiol."},{"key":"10.1016\/j.biopha.2018.06.076_bib0105","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J. Cardiol."},{"issue":"1","key":"10.1016\/j.biopha.2018.06.076_bib0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","article-title":"Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"32","author":"Nathan","year":"2009","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.biopha.2018.06.076_bib0115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1464-5491.2006.01996.x","article-title":"Oxidative burden in prediabetic and diabetic individuals: evidence from plasma coenzyme Q(10)","volume":"23","author":"Lim","year":"2006","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.076_bib0120","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/healthcare3020296","article-title":"Supplementation of coenzyme Q10 among patients with type 2 diabetes mellitus","volume":"3","author":"Shen","year":"2015","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.biopha.2018.06.076_bib0125","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1291\/hypres.28.385","article-title":"Blood pressure reduction and cardiovascular prevention; an update including the 2003-2004 secondary prevention trials","volume":"28","author":"Staessen","year":"2005","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.biopha.2018.06.076_bib0130","first-page":"117","article-title":"Nutraceuticals for blood pressure control in patients with high-normal or grade 1 hypertension","volume":"19","author":"Trimarco","year":"2012","journal-title":"High Blood Press. Cardiovasc. Prev."},{"issue":"7","key":"10.1016\/j.biopha.2018.06.076_bib0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12325-015-0229-x","article-title":"Nutraceuticals for serum lipid and blood pressure control in hypertensive and hypercholesterolemic subjects at low cardiovascular risk","volume":"32","author":"Mazza","year":"2015","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.biopha.2018.06.076_bib0140","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1074248407300380","article-title":"Do statins lower blood pressure?","volume":"12","author":"Mangat","year":"2007","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.biopha.2018.06.076_bib0145","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1161\/01.HYP.0000259737.43916.42","article-title":"Do statins reduce blood pressure?: A meta-analysis of randomized, controlled trials","volume":"49","author":"Strazzullo","year":"2007","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.biopha.2018.06.076_bib0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1177\/1470320314531058","article-title":"Statins, the renin-angiotensin-aldosterone system and hypertension\u2013a tale of another beneficial effect of statins","volume":"15","author":"Drapala","year":"2014","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"issue":"10","key":"10.1016\/j.biopha.2018.06.076_bib0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/jhh.2011.80","article-title":"Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study","volume":"26","author":"Kanaki","year":"2012","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.biopha.2018.06.076_bib0160","series-title":"Your Guide to Lowering Your Blood Pressure With DASH","author":"US Department of Health and Human Services","year":"2006"},{"key":"10.1016\/j.biopha.2018.06.076_bib0165","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM199704173361601","article-title":"A clinical trial of the effects of dietary patterns on blood pressure","volume":"336","author":"Appel","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2018.06.076_bib0170","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/jhh.2009.58","article-title":"DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre. Randomized controlled trial","volume":"24","author":"Al-Solaiman","year":"2010","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.biopha.2018.06.076_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078412","article-title":"Compliance with the Aietary Approaches to Stop Hypertension (DASH) diet: a systematic review","volume":"8","author":"Kwan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2018.06.076_bib0180","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007435.pub2","article-title":"Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension","volume":"4","author":"Ho","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.biopha.2018.06.076_bib0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2217\/clp.15.37","article-title":"Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia","volume":"10","author":"Gentile","year":"2015","journal-title":"Clin. Lipidol."},{"issue":"11","key":"10.1016\/j.biopha.2018.06.076_bib0190","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00007611-200111000-00015","article-title":"Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension","volume":"94","author":"Burke","year":"2001","journal-title":"South. Med. J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218327628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332218327628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:42:25Z","timestamp":1731447745000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332218327628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":38,"alternative-id":["S0753332218327628"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.076","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2018.06.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}